Jen Ward retweeted
Hot off the #JAAD press!
Langerhans Cell Histiocytosis Presenting in the Skin in Adults: Clinical Patterns & Outcomes with Skin-Directed Therapy
Free access until Nov 7
➡️authors.elsevier.com/c/1loEc…
🙏 to @JenWard1234, our brilliant skin lymphoma team @PeterMacCC & @JAADjournals
Jen Ward retweeted
Replying to @AlfredHealth
@AlfredHealth Radiation Oncology team well-represented at #RANZCR2024 with multiple presentations by our fellow and registrars!
@jeremymillar @theresekang_ @JenWard1234 @PerryLin612
Jen Ward retweeted
Well done to super⭐️ #radonc registrar, @JenWard1234 - invited speaker in the session on #RT for #benign diseases at #ESTRO24. 👏 Brilliantly presenting our data of ultra-low dose RT for cutaneous CD4+ small/medium T-cell LPD. 100% CR from only 2Gy x2. @PeterMacCC @ESTRO_RT
Jen Ward retweeted
Congratulations to ⭐️ #radonc registrar @JenWard1234 for this first author randomised control trial. 👏👏👏
onlinelibrary.wiley.com/doi/…
Published in @JMIRO_Journal.
@PeterMacCC @RANZCRcollege @SukiGill01 @KevinAr84188131
Jen Ward retweeted
Well done to @PeterMacCC RadOnc registrar Jen Ward & physicist Vanessa Panettieri on their @TROGfightcancer awards. Strong representation by @PeterMacCC team at #trog2023 - shaping the future or radiation oncology @TargetingCancer
Jen Ward retweeted
Well done @JenWard1234 et al 🙌
Ultra low dose #RT (4Gy in 2#) for cutaneous CD4+ small/medium T-cell LPD: 100% CR, 0% acute toxicity authors.elsevier.com/a/1gCfU… Free access ‘til Jan 25 thanks to @RadiotherapyOn1 @AustralasianLy1 @PeterMacCC @RANZCRcollege @ILROGTeam @WomenInLymphoma
Jen Ward retweeted
Good luck to all presenters #RANZCRASM21! Proud to see @PeterMacCC on stage @HardcastleNick @_ShankarSiva @NickWBucknell @DavidCh88224451 @_joesia Mary Xu @cristian_udo Lessy Chee, @JenWard1234 Kendrick Koo, Qichen Zhang @DrKeelan @DrDavidKok Keen Hun Tai @phillips_ce @gerryhanna










